ULK1 and diabetic kidney disease: CAMMKK2, acting as an upstream kinase of AMPK, phosphorylates the AMPK/ULK1 pathway, restoring autophagy activity and potentially reducing inflammation, thereby delaying DKD progression and HK-2 cell injury (Li et al. 2022a).